Polaris Venture Management Co. V as of Dec. 31, 2017
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 10 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kala Pharmaceuticals | 30.3 | $34M | 1.9M | 18.49 | |
| Arsanis | 21.0 | $24M | 1.9M | 12.76 | |
| Selecta Biosciences (RNAC) | 13.9 | $16M | 1.6M | 9.81 | |
| Fate Therapeutics (FATE) | 13.3 | $15M | 2.5M | 6.11 | |
| T2 Biosystems | 6.8 | $7.7M | 1.9M | 4.12 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 5.6 | $6.4M | 1.8M | 3.50 | |
| Pulmatrix | 3.5 | $3.9M | 2.8M | 1.41 | |
| Trevena | 2.9 | $3.3M | 2.1M | 1.60 | |
| Genocea Biosciences | 2.0 | $2.3M | 2.0M | 1.16 | |
| Dare Bioscience (DARE) | 0.6 | $705k | 326k | 2.16 |
